Membrane-type matrix metalloproteinases (MT-MMPs) 1 are a newly described family of MMPs (1) that are distinguished by their localization to the plasma membranes of cells by a stretch of hydrophobic amino acids (transmembrane domain) (2). MTMMPs have been the subject of intense interest because of their role in activating a secreted MMP, progelatinase A, at the cell surface (1) and in directly cleaving collagen and other extracellular matrix proteins (3). Because activation of all soluble latent MMPs described to date is accompanied by cleavage of the N-terminal propeptide, thereby exposing the active site zinc by dissociation from the conserved cysteine in the prodomain, the assumption has been made that an analogous mechanism is responsible for the activation of MT1-MMP on the cell surface.
Membrane-type matrix metalloproteinases (MT-MMPs) 1 are a newly described family of MMPs (1) that are distinguished by their localization to the plasma membranes of cells by a stretch of hydrophobic amino acids (transmembrane domain) (2) . MTMMPs have been the subject of intense interest because of their role in activating a secreted MMP, progelatinase A, at the cell surface (1) and in directly cleaving collagen and other extracellular matrix proteins (3) . Because activation of all soluble latent MMPs described to date is accompanied by cleavage of the N-terminal propeptide, thereby exposing the active site zinc by dissociation from the conserved cysteine in the prodomain, the assumption has been made that an analogous mechanism is responsible for the activation of MT1-MMP on the cell surface.
Utilizing recombinant wild-type (wt) MT1-MMP cDNA and mutant MT1-MMP cDNAs transfected into cells lacking endogenous MT1-MMP, we have recently examined the function of the N-terminal propeptide domain of membrane-bound MT1-MMP. Contrary to expectation, we demonstrated that the Nterminal prodomain of wt MT1-MMP is required for function of the intact membrane-bound enzyme in COS-1 cells. Transfected COS-1 cells containing a deletion of the N-terminal propeptide domain of MT1-MMP or a chimeric construction in which the prodomain of MT1-MMP is substituted by the Nterminal propeptide domain of collagenase-3 were functionally inactive in terms of binding 125 I-labeled TIMP-2 to the cell surface and in initiating the activation of progelatinase A (4) . These data led us to hypothesize that in its native plasma membrane-inserted form, the prodomain of MT1-MMP serves to facilitate the function of MT1-MMP as a receptor for TIMP-2 that subsequently immobilizes progelatinase A, thereby forming a trimolecular complex on the cell surface. A second free MT1-MMP molecule is then required to cleave the prodomain leading to activation of membrane-bound progelatinase A. The presence of excess TIMP-2 saturates all available MT1-MMP molecules, thereby interfering with progelatinase A activation. We proposed that conformational effects induced by the plasma membrane provide functional activity to latent cell surfacebound MT1-MMP without cleavage of the molecule (4, 5) . It needs to be emphasized that our understanding of the importance of the propeptide domain of MT1-MMP was possible only because COS-1 cells are defective in proteolytic processing of certain newly synthesized proteins (6) . Even following co-transfection of furin cDNA and MT1-MMP cDNA, COS-1 cells do not process latent MT1-MMP (63 kDa) to mature MT1-MMP (58 kDa) (7) . In contrast, both the latent and mature forms of MT1-MMP are prominently displayed in several types of nontransfected cells capable of inducing progelatinase A activation (5, 8, 9) ; hence it was not previously possible to distinguish between the function of native versus mature enzyme.
The goal of this report is to further clarify the role of the propeptide domain of MT1-MMP in maintaining the function of the plasma membrane-inserted enzyme. To this end, we have independently transfected or co-transfected COS-1 cells (in trans form) with the N-terminal prodomain cDNA for MT1-MMP and MT1-MMP cDNA lacking the propeptide domain (mature sequence). The results demonstrate that synthesis of the prosequence is required to obtain functional MT1-MMP and that a covalent link of the prosequence with the mature sequence of MT1-MMP in COS-1 cells is not required.
MATERIALS AND METHODS
Reagents-Chemical reagents were purchased from Sigma. Restriction enzymes were purchased from Stratagene (La Jolla, CA). The pcDNA3 expression vector was purchased from Invitrogen (San Diego, CA). The monoclonal antibody to hemagglutinin (HA) tag was purchased from Roche Molecular Biochemicals (clone 12 CA5). Rabbit polyclonal antibodies to a synthetic peptide (CDGNFDTVAMLRGEM) within the catalytic domain (10) , to the hinge region of MT1-MMP (Chemicon International, Temecula, CA), and to the prodomain of MT1-MMP (Chemicon) were employed. Recombinant progelatinase A, produced by COS-1 cells transfected with gelatinase A cDNA, was purified as described previously (2, 7). Interstitial collagenase-1 cDNA was generously provided by Dr. Chitra Biswas (Tufts University School of Medicine) (11) .
Cell Culture and Transfection-COS-1 cells were maintained in Dulbecco's modified Eagle's medium (Life Technologies, Inc.) containing 10% fetal bovine serum (Life Technologies, Inc.) and 2 mM glutamine under 5% CO 2 atmosphere. Plasmids were transfected into cells using calcium phosphate as described previously (2) .
Construction of Plasmids-MT1-MMP cDNA encoding an open reading frame from amino acid residues Met l -Va1 582 and mutant MT1-MMP were cloned in a pcDNA3 expression vector employing a cytomegalovirus promoter (4) . MT⌬pro lacking the entire N-terminal propeptide domain was utilized in this study as we have previously described (4) . A chimera between collagenase-3 and MT1-MMP (Col-3/MT) was constructed by a two-step polymerase chain reaction using the introduced collagenase-3 fragment encoding the N-terminal signal and propeptide domain (from Met 1 to Arg 95 ) in an MT1-MMP plasmid that lacked the N-terminal signal and propeptide domains (from Met 1 to Arg 92 ) as we previously described (4). To generate a mutation expressing the Nterminal propeptide of MT1-MMP (MT ), a polymerase chain reaction fragment encoding for the entire signal and propeptide domains of MT1-MMP (Met l -Arg 109 ) (12) was amplified using the MT1-MMP cDNA template with the forward primer 1094 (5Ј to 3Ј, CACGAATTCCGGAC-CATGTCTCCCGCCCCAAGA) and the reverse primer 1095 (5Ј to 3Ј, AAGGATCCCCTTCGAACATTGGCCTTGA). The polymerase chain reaction product was inserted in pcDNA3 expression vector with EcoRI and BamHI sites. Employing the same strategy, a truncated interstitial collagenase-1 (MMP-1) expressing N-terminal signal and propeptide domains (MMP-1 ) was constructed with the forward primer 1096 (5Ј to 3Ј, AATACGACTCACTATAG) and the reverse primer 1097 (5Ј to 3Ј, AAGGATCCCTGAGCCACATCAGGCACTC) and inserted in pcDNA3 vector.
A sequence encoding the influenza HA, YPYDVPDYA (13) at the 5Ј end was inserted in frame with the coding sequence of mutations of MT1-MMP 1-109 or MMP-1 1-99 to generate MT 1-109 /HA and MMP-1 1-99 / HA. All of the mutants were confirmed by sequencing as described previously (7).
Cell Surface Binding of TIMP-2-Recombinant TIMP-2 (rTIMP-2) was iodinated as we recently described (4). Binding of I-labeled TIMP-2 was measured by gamma counting. The residual radioactivity associated with cells in the nonspecific binding experiment (20-fold excess TIMP-2) was subtracted from the total bound fraction (no unlabeled TIMP-2) to give specific binding. Scatchard plot analysis of binding data employed best-fit curves (4) .
Immunofluorescence-COS-1 cells were transfected with MT⌬pro, MT1-MMP, or pcDNA3 vector and seeded on glass coverslips precoated with 50 g/ml type I collagen (Vitrogen 100; Cohesion, Palo Alto, CA). After 24 h, cells were washed with PBS and fixed in 3.7% formaldehyde in PBS for 10 min at 37°C followed by permeabilization of cells with 0.1% Nonidet P-40 for 10 min at 4°C. Cells were then blocked with 1% rabbit serum/PBS for 30 min and subsequently incubated with rabbit anti-MT1-MMP hinge antibody for 2 h at 22°C. The coverslips were then washed four times, followed by incubation with a fluorescein isothiocyanate-conjugated goat anti-rabbit IgG antibody (Chemicon) for 2 h at 22°C. After extensive washes, the coverslips were mounted on glass microscope slides with anti-fading medium (Vectashield-Vector Laboratories Inc., Burlingame, CA). The cells were viewed and photographed with a Nikon confocal fluorescent microscope.
Gelatin Substrate Zymography and Western Blotting-Basic protocols for these techniques have been described in our recent papers (4, 7, 10) . Western blotting for proteins Ͻ15 kDa was done using a modification of the tricine-SDS method involving 0.1 M tricine, 0.1% SDS, pH 8.25, in a cathode buffer and 0.2 M Tris, pH 8.9, in the anode buffer (14) . The electrophoresed proteins in the gel were transferred onto 0.5% gelatin-coated nitrocellulose paper at 55 V for 2 h. The blotting membrane was blocked, followed by addition of the primary antibody (antibody to the propeptide of MT1-MMP or antibody to HA tag) and then the secondary antibody (horseradish peroxidase-conjugated anti-rabbit IgG) as we previously described (4, 7, 10) . Immunoreactive bands were detected by enhanced chemiluminescence (ECL, Amersham Pharmacia Biotech). signal peptide and the entire propeptide domain was constructed and transfected into COS-1 cells as depicted in Fig. 1 . Western blotting of conditioned media from the transfected COS-1 mutant MT , using an antibody to the propeptide domain of MT1-MMP, resulted in staining of a single protein band migrating predictably at ϳ9 kDa based on its truncated length ( Fig. 2A) .
RESULTS

Synthesis of Mutant Propeptide Domains of MT1-MMP by
Co-expression of MT⌬pro with MT in COS-1 Cells Induced Progelatinase A Activation-2 ϫ 10 5 COS-1 cells were transiently transfected with progelatinase A cDNA, as well as pcDNA3 vector, MT1-MMP cDNA, MT 1-109 , MT⌬pro cDNA, or MT⌬pro cDNA along with MT 1-109 cDNA. 24 h post-transfection, the enriched media was switched to serum-free media, and conditioned media was collected over the subsequent 18 h. As shown by gelatin zymography (Fig. 2B) , expression of progelatinase A and MT1-MMP in COS-1 cells resulted in activation of the latent enzyme as depicted by the appearance of a 62-kDa gelatinolytic band. Co-expression of MT and MT⌬pro in COS-1 cells in trans form, i.e. as independent polypeptides, along with progelatinase A cDNA, resulted in activation of progelatinase A in a dose-dependent fashion; neither cDNA construct transfected alone into COS-1 cells resulted in progelatinase A activation. These data are consistent with the concept that the independently synthesized soluble prodomain of MT1-MMP is associated with prodomain-deleted MT1-MMP and is expressed at the cell surface leading to functional activity (activation of progelatinase A), thereby recapitulating the function of the intact MT1-MMP molecule. The combined effect of MT and MT⌬pro was inhibited by transfecting these cells with excess TIMP-2 cDNA (Fig. 3) . We previously reported the same inhibitory effect of TIMP-2 on wt MT1-MMP activation of progelatinase A (5). A similar profile of MT 1-109 cDNA and MT⌬pro cDNA reconstituting gelatinase A activation function in transfected cells encoding the cDNA was also documented with Chinese hamster ovary cells (data not shown).
To examine the specificity of these observations, we determined whether the prodomain of MT1-MMP is able to provide function to an inactive chimeric mutation of MT1-MMP in which the propeptide domain of MT1-MMP is replaced by the propeptide domain of collagenase-3 (Col-3/MT). COS-1 cells, transiently transfected with both MT 1-109 cDNA and Col-3/MT cDNA (Fig. 3, lane 5) , did not activate progelatinase A. In this construct, the isolated prodomain of MT1-MMP presumably is unable to displace the prodomain of the inactive chimeric molecule; hence, activation of progelatinase A does not occur. We further determined whether the prodomain of a secreted MMP (MMP-1) was able to reconstitute the function of MT⌬pro (Fig. 4) . To this end, MMP-1 1-99 cDNA was co-transfected into COS-1 cells in trans along with MT⌬pro cDNA; 24 h later recombinant progelatinase A was added, and cells were incubated as described above. Gelatin substrate zymography demonstrated that co-transfection with MMP-1 did not alter the lack of function of MT⌬pro. Synthesis of MMP-1 1-99 by transfected COS-1 cells was documented by the introduction of an influenza HA epitope in the C terminus of MMP-1 . Western blotting of conditioned medium using an anti-HA antibody demonstrated a peptide of approximately 11 kDa, consistent with the anticipated molecular mass of MMP-1 . To determine whether the HA epitope might alter function of an MMP prodomain, the HA epitope was added to the cDNA for MT . The HA tag did not impair the reconstitution of MT with MT⌬pro as shown by functional assay in terms of progelatinase A activation. This result is consistent with the specific requirement for the prodomain of MT1-MMP for function of the molecule in cells.
We next examined the effect of adding the recombinant Nterminal propeptide domain of MT1-MMP to COS-1 cells transfected with MT⌬pro cDNA. Recombinant MT 1-109 protein isolated from conditioned medium of COS-1 cells transfected with MT 1-109 cDNA did not reconstitute the activation of progelatinase A by COS-1 cells transfected with MT⌬pro (Fig. 5) . This result suggests that the association between MT⌬pro and MT 1-109 protein takes place intracellularly during synthesis, folding, and transport of these proteins to the plasma membrane and cannot be replicated after insertion of MT⌬pro in the plasma membrane (4) . (Fig. 6) . These results were reproduced in two other experiments with the K d being ϳ1.6-fold higher and the receptor number being ϳ7-fold higher in the wt MT1-MMP-transfected cells as compared with the dual-transfected cells.
Binding of 125 I-labeled TIMP-2 to the Reconstituted MT1-MMP Molecule in COS-1 Cells-In
Cellular Localization of MT1-MMP-To examine the localization of MT⌬pro, immunostaining and confocal fluorescent microscopy were performed. Both wt MT1-MMP and MT⌬pro were identified on the cell surface (Fig. 7) . Perinuclear staining (consistent with Golgi apparatus) was more prominent with MT⌬pro than wt MT1-MMP-transfected cells. No fluorescence was noted in vector-transfected cells (negative control). These data are consistent with delayed trafficking of MT⌬pro to the Golgi apparatus and the plasma membrane. Taken together, these data suggest that the N-terminal propeptide of MT1-MMP functions as a chaperone involved in protein folding and trafficking to the plasma membrane.
DISCUSSION
The unique feature of MT-MMPs is their insertion into the plasma membrane of cells by a stretch of hydrophobic amino acids followed by a short cytoplasmic sequence. Because purified MT-MMPs cannot readily be evaluated in their membranebound state, most experiments designed to study the function of MT-MMPs have employed secreted (soluble) mutant MT1-MMP recombinants lacking the transmembrane domain (15) (16) (17) (18) . Based on these studies, it has been concluded that cleavage of the N-terminal domain of membrane-bound MT-MMPs by furin, presumably in the trans-Golgi network, is required for function of the enzyme in activating progelatinase A and degrading other substrates (15, 16, 18, 19) .
Recent reports by Cao et al. (4) and Butler et al. (20) have demonstrated that membrane-bound MT1-MMP reacts differently than soluble MT1-MMP (extracted from cell membranes by detergents or membrane domain-deleted MT1-MMP). Stoichiometric concentrations of TIMP-2, which forms an essential bridge between plasma membrane MT1-MMP and progelatinase A at the cell surface, are not required for activation of progelatinase A by soluble MT1-MMP (20) . As with naturally secreted MMPs, TIMP-2 function is limited to binding and inhibition of enzymatic activity of soluble prodomain-deleted MT1-MMP (16, 18, 20) . We further demonstrated that cleavage of the N-terminal prodomain of MT1-MMP on the surface of transfected COS-1 cells was not required for function of the enzyme in terms of binding TIMP-2 and activating progelatinase A. In other cell types (i.e. endothelial cells, HT-1080 fibrosarcoma (9)), however, furin-induced cleavage of the N terminus is required for function of MT-MMP.
To further examine the function of the prodomain of membrane-bound MT1-MMP, we herein have studied the effect of transfecting COS-1 cells with cDNA encoding the propeptide sequence of MT1-MMP (MT ) in trans with MT1-MMP cDNA lacking the propeptide domain (MT⌬pro). This co-transfection, leading to independent synthesis of MT and MT⌬pro proteins, resulted in reconstitution of MT1-MMP function in terms of binding TIMP-2 and activating progelatinase A at the cell surface. These results are consistent with the concept that the isolated propeptide domain of MT1-MMP is able to associate (presumably in the endoplasmic reticulum) with the remainder of the MT1-MMP molecule (catalytic/hinge/hemopexin domain) prior to trafficking to the plasma membrane and provide function to the reconstituted protein. However, the number of functioning MT-MMP units on the cell surface is diminished, presumably because of decreased efficiency of the binding process in the endoplasmic reticulum. For unexplained reasons, the dissociation constant (K d ) for TIMP-2 binding to non-covalent linked, reconstituted MT1-MMP was reproducibly lower than that of the wild-type enzyme.
Co-transfection of COS-1 cells with the chimeric Col-3/MT cDNA and MT 1-109 cDNA or MT⌬pro cDNA and MMP-1 1-99 cDNA did not reconstitute progelatinase A activation function. These experiments strengthen our proposition that the isolated prodomain of MT1-MMP is capable of non-covalent bonding with MT⌬pro, presumably in the endoplasmic reticulum/Golgi apparatus prior to trafficking to the plasma membrane.
Additional studies will be required to determine which amino acids in the prodomain are essential for enzyme function. As depicted in Fig. 1B , the sequence YGYLP is highly conserved in the propeptide of all MT-MMP subfamily members described to date, which leads us to suspect an important function for this sequence. Our previous study of membraneinserted mutants of MT1-MMP suggested an important role of the Ser 34 -Arg 51 region of the prodomain (4), but it should be pointed out that a large deletion of this type may exert a deleterious effect on protein structure and stability. In con 
